M&A Deal Summary |
|
|---|---|
| Date | 2024-07-23 |
| Target | Trukera Medical |
| Sector | Medical Products |
| Buyer(s) | Bausch & Lomb |
| Sellers(s) |
Accelmed
CRG |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1853 |
| Sector | Medical Products |
| Revenue | 3.3B USD (2013) |
Bausch & Lomb is a manufacturer of ophthalmic products.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 7 |
| Sector (Medical Products) | 5 of 5 |
| Type (Add-on Acquisition) | 5 of 5 |
| State (Texas) | 1 of 1 |
| Country (United States) | 4 of 4 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-06-30 |
Xiidra
Basel, Switzerland XIIDRA (lifitegrast ophthalmic solution) 5% is a prescription eye drop used to treat the signs and symptoms of dry eye disease. Xiidra is based in Basel, Switzerland. |
Buy | - |
Accelmed is a global investment firm focused on providing investments in small and mid-cap private and public companies. The Firm looks to invest between $20 and $50 million in medical device companies and technologies with revenues greater than $30 million. Prospective transaction types include management buyouts and growth financings. Accelmed was formed in 2009 and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector (Medical Products) | 2 of 2 |
| Type (Add-on Acquisition) | 1 of 1 |
| State (Texas) | 1 of 1 |
| Country (United States) | 2 of 2 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-10-22 |
Click Therapeutics
New York, New York, United States Click Therapeutics develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Click Therapeutics was founded in 2012 and is based in New York City. |
Buy | - |
CRG is a healthcare focused investment firm focused on growth capital to commercial-stage public and private companies. CRG looks to commit $20 to $300 million that are developing next-generation healthcare products, technologies and services that address significant and substantial unmet medical needs. Specific areas of interest include biopharmaceuticals, specialty pharmaceuticals, medical devices, drug delivery, animal health, tools and diagnostics, and healthcare services. CRG was formed in 2003 and is headquartered in Houston, Texas.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector (Medical Products) | 1 of 1 |
| Type (Add-on Acquisition) | 2 of 2 |
| State (Texas) | 1 of 1 |
| Country (United States) | 3 of 3 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-04-18 |
Sanara MedTech
Fort Worth, Texas, United States Sanara MedTech is an entity which markets and distributes wound and skin care products and is seeking to offer wound care and dermatology virtual consultation services via telemedicine to physicians, hospitals, clinics, and all post-acute care settings. Sanara's products are primarily sold in the North American advanced wound care and surgical tissue repair markets. Sanara MedTech was founded in 2001 and is based in Fort Worth, Texas. |
Buy | - |
